Celltrion Healthcare Co., Ltd.
KRX
✓Strengths
- Comfortable interest cover: operating profit covers interest about 3.9 times.
- Return on capital employed is moderate at 10.4%.
- Net profit margin is 7.5%.
- Current assets comfortably cover current liabilities (current ratio 1.9).
- Profit has compounded about 31% a year over five years.
- Sales have compounded about 21% a year over five years.
- Pays a dividend (yield about 0.2%).
!Watch-points
- Higher leverage: debt-to-equity of 1.16 is above 1.
- Return on equity is on the lower side at 7.1%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
1.42
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
1 / 4
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 4 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 13,292.45
Dividend Yield0.20%
ROCE10.36%
ROE7.14%
Debt to Equity1.16
Current Ratio1.90
EPS₩ 949.00
PAT Margin7.46%
ICR3.86
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity